Special Issue "Antibacterial, Antibiofilm and Anti-virulence Activity Research of both Natural and Synthetic Products"
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 15 March 2021.
Interests: antimicrobial agent; antibiofilm agent; anti-virulence agent; bacterial pathogenesis; bacterial repeat proteins; acinetobacter baumannii; staphylococcus aureus
Antimicrobial resistance is becoming a global public health treat. The excessive use of traditional antibiotics has resulted in the emergence of multidrug resistance of microorganisms. Multidrug-resistant (MDR) species tend to exhibit high levels of resistance to many antibiotic drug classes, causing infections which are difficult to treat with conventional antibiotic therapies. The ability to form well-organized biofilm makes bacteria highly resistant to the available antibiotics. Despite intensive efforts searching for new antimicrobial agents, there are few active candidates, and new anti-infectives that act through different mechanisms of action are needed. A promising alternative strategy to treat infections caused by MDR bacteria is antivirulence therapy, which is based on the development of drugs able to specifically inhibit virulence factors. The aim of this Special Issue is to present a collection of manuscripts that explore newly discovered antibacterial agents as well as their mode of action in bacteria.
Potential topics may include but are not limited to:
- Discovery and/or molecular mechanisms of novel compounds with bactericidal or bacteriostatic activity
- Discovery and/or molecular mechanisms of novel compounds with activity against bacterial and/or fungal biofilm
- Discovery and molecular mechanisms of novel compounds targeting bacterial virulence factors such as quorum sensing, biofilm formation, motility, toxins, and pigments
Dr. Eliana De Gregorio
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antimicrobial agent
- antibiofilm agent
- synergy between new antimicrobial products and conventional antibiotics
- anti-virulence agent
- mechanism of drug action
- repurposing of approved drugs as antibacterial agent
- virulence factors